Sumatriptan

CAS 103628-46-2 4 current records 3 historicalSmall Molecule

Who holds supplier records for Sumatriptan? 4 organisations hold a current record for Sumatriptan: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3) and Spain (1).

Most records are filed under another form of this substance: Sumatriptan Succinate (13 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Sumatriptan: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sumatriptan

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    3 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Sumatriptan expires 29 Jan 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Sumatriptan. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Divis Laboratories
    Active DMF 23624 · latest filing Mar 2010
    India Company GMP cert on record
  • MOEHS IBERICA SL
    Active DMF 24026 · latest filing Aug 2010
    Spain
  • MSN PHARMACHEM PRIVATE LTD
    Active DMF 23442 · latest filing Jan 2010
    India
  • SMS Pharmaceuticals limited
    Active DMF 18287, 20906 · latest filing Oct 2007
    India Company GMP cert on record
Need Sumatriptan sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (3)

Organisations whose Type II DMFs for Sumatriptan are no longer active. These show a past filing, not current supply.

Show all 3 historical records

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (51 listed products contain Sumatriptan). The latest listed patent expires 29 Jan 2036. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Sumatriptan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL128).

Chemical identity

IUPAC name
1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide
Canonical SMILES
CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
InChIKey
KQKPFRSPSRPDEB-UHFFFAOYSA-N
Synonyms
Dfn-11, Dfn-11 (sumatriptan injection), Imitrex, N02CC01, Sumatriptan, Tosymra, Sumatran, Sumax, Imigran, Sumatriptanum, Imigran Recovery, CHEBI:10650

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin-1b and Serotonin-1d Receptor Agonist
Mechanism of action
Serotonin 1b Receptor Agonists; Serotonin 1d Receptor Agonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Sumatriptan?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Sumatriptan: Divis Laboratories (India), MOEHS IBERICA SL (Spain), MSN PHARMACHEM PRIVATE LTD (India) and SMS Pharmaceuticals limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Sumatriptan Drug Master Files are active?

Divis Laboratories (DMF 23624), MOEHS IBERICA SL (DMF 24026), MSN PHARMACHEM PRIVATE LTD (DMF 23442) and SMS Pharmaceuticals limited (DMF 18287, 20906). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Sumatriptan records mean?

3 organisations have only inactive Type II DMFs for Sumatriptan. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does the FDA Orange Book list patents for products containing Sumatriptan?

Yes. The latest patent listed for an approved US product containing Sumatriptan expires 29 Jan 2036, across 51 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Sumatriptan supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Sumatriptan?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.